DOJ Orders Immediate Reclassification of Medical Marijuana Products
Quick Hits The DOJ ordered the reclassification of certain marijuana and marijuana-containing products from Schedule I to Schedule III controlled substances, potentially reshaping medical research and employer policies around its use. Reclassification could lead to more medical research on marijuana and other non-employment-related impacts. Reclassification could also have implications for employers, including the handling of employees who are medical marijuana cardholders, analysis of workplace accommodation requests, and maintaining drug testing…

